Home » Newsletters » BioWorld Science

BioWorld Science

March 21, 2007

View Archived Issues

Antiproliferative effect of eicosapentaenoic acid reported in pancreatic cancer cells

Snapshots: The American Society for Clinical Pharmacology and Therapeutics meeting

ATC reduces replication of HIV virus in patients with drug-resistant disease

Corlux shows correlation between plasma levels and clinical outcome in PMD

First results show AGI-1067 did not meet primary endpoint of ARISE trial

Vascular Wrap Paclitaxel-Eluting Mesh begins U.S. pivotal study

New collaboration for development of IV Artesunate

Enrollment begins in phase II trials of Vascugel

Chromos proposing collaboration for CHR-1103

Enrollment completed in final phase III study for ferumoxytol

POT-4 enters clinical development for AMD

New vaccine approach for the treatment of Alzheimer's disease

NKDCs suggested as a candidate immunotherapy for lung metastases

Multimodal therapy with TNFerade suggested for cholangiocarcinoma

Natural fungal product shows antimyeloma activity in vitro and in vivo

NAP reduces tau hyperphosphorylation in vivo

Bevacizumab/rapamycin combination effective in managing peritoneal disease from ovarian cancer

Novel radiolabeled Affibody conjugate shows antitumor efficacy in vivo

Novel drug promotes differentiation of neural stem cells via modulation of the Notch/Hes pathway

IND for second siRNA therapeutic based on SR Pharma chemistry

Ramelteon filed in E.U. for primary insomnia

Takeda warns on increased risk of fractures associated with pioglitazone

FDA approves Keppra for primary generalized tonic-clonic seizures

Approvable letter for Prograf plus MMF in kidney transplant patients

Recent patents disclose novel therapeutic agents for respiratory disorders

Recent patents cover new therapeutic agents for nutritional disorders such as obesity

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...